1. Home
  2. SABS vs GWH Comparison

SABS vs GWH Comparison

Compare SABS & GWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABS
  • GWH
  • Stock Information
  • Founded
  • SABS 2014
  • GWH 2011
  • Country
  • SABS United States
  • GWH United States
  • Employees
  • SABS N/A
  • GWH N/A
  • Industry
  • SABS Biotechnology: Pharmaceutical Preparations
  • GWH Industrial Machinery/Components
  • Sector
  • SABS Health Care
  • GWH Miscellaneous
  • Exchange
  • SABS Nasdaq
  • GWH Nasdaq
  • Market Cap
  • SABS 15.8M
  • GWH 17.9M
  • IPO Year
  • SABS N/A
  • GWH N/A
  • Fundamental
  • Price
  • SABS $2.75
  • GWH $1.58
  • Analyst Decision
  • SABS Strong Buy
  • GWH Hold
  • Analyst Count
  • SABS 5
  • GWH 5
  • Target Price
  • SABS $11.80
  • GWH $2.10
  • AVG Volume (30 Days)
  • SABS 37.3K
  • GWH 379.1K
  • Earning Date
  • SABS 08-07-2025
  • GWH 08-13-2025
  • Dividend Yield
  • SABS N/A
  • GWH N/A
  • EPS Growth
  • SABS N/A
  • GWH N/A
  • EPS
  • SABS N/A
  • GWH N/A
  • Revenue
  • SABS $377,835.00
  • GWH $4,155,999.00
  • Revenue This Year
  • SABS N/A
  • GWH $168.75
  • Revenue Next Year
  • SABS N/A
  • GWH $188.35
  • P/E Ratio
  • SABS N/A
  • GWH N/A
  • Revenue Growth
  • SABS N/A
  • GWH N/A
  • 52 Week Low
  • SABS $1.00
  • GWH $0.76
  • 52 Week High
  • SABS $5.01
  • GWH $13.34
  • Technical
  • Relative Strength Index (RSI)
  • SABS 75.33
  • GWH 56.59
  • Support Level
  • SABS $2.31
  • GWH $1.27
  • Resistance Level
  • SABS $2.98
  • GWH $1.76
  • Average True Range (ATR)
  • SABS 0.24
  • GWH 0.23
  • MACD
  • SABS 0.09
  • GWH 0.04
  • Stochastic Oscillator
  • SABS 89.31
  • GWH 80.00

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About GWH ESS Tech Inc.

ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. The company design and produce long-duration batteries predominantly using earth-abundant materials.

Share on Social Networks: